Document Detail


Cardiovascular excitatory effect on rats of a fraction isolated from the eyestalk of shrimp: Peneaus vanameii.
MedLine Citation:
PMID:  16886775     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The crustacean nervous system is an important source of substances with diverse biological activities, particularly affecting invertebrate cardiocirculatory physiology. However, the effects of these substances on the cardiovascular system of higher vertebrates are not very well documented. The purpose of this study was to evaluate the effects of a cardioexcitatory substance (CES) isolated from the eyestalk of the shrimp Peneaus vanameii on rat cardiovascular function. The administration of a purified fraction of this substance raised mean arterial pressure by 37.33 +/- 5.00 mm Hg, pulse pressure 35.00 +/- 4.93 mm Hg and heart rate 80.00 +/- 12.83 beats/min over basal values (p < 0.01). Evaluation of the possible underlying mechanisms of this hypertensive and tachycardic effect reveled that dihydroergotamine pretreatment (20 microg/0.2 mL) reduced the effect of CES on mean blood pressure, but not on heart rate. Propranolol pretreatment (4 microg/0.2 mL) reduced the tachycardia, but not the hypertensive response. Enalapril pretreatment (5 microg/0.2 mL) did not modify the effects induced by CES on heart rate or blood pressure, and the verapamil pretreatment (1 microg/0.2 mL) reduced both cardiovascular changes by 85% (p < 0.01). These results indicate that CES isolated from the shrimp eyestalk produces hypertension and tachycardia mediated by adrenergic receptors in association to calcium channels activation.
Authors:
Francisco Rosa; Jesús Cedeño; Luis León; Omar Estrada; Eduardo Romero-Vecchione; José Vásquez; Rafael Antequera
Related Documents :
25215435 - Relative impact of blood pressure as compared to an excess adiposity on left ventricula...
7923305 - Long-acting nicardipine for elderly hypertensive patients: effect on diurnal variation ...
25380165 - Portable indices for sarcopenia are associated with pressure wave reflection and centra...
3310745 - Changes in systemic and pulmonary vascular reactivity in hypertension following nifedip...
7117335 - Altered portal pressure secondary to portacaval and portasystemic shunts in the rat: th...
16174995 - Hypertension in cancer patients seeking acute care: an opportunity to intervene.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Investigación clínica     Volume:  47     ISSN:  0535-5133     ISO Abbreviation:  Invest Clin     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-08-04     Completed Date:  2006-09-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0421531     Medline TA:  Invest Clin     Country:  Venezuela    
Other Details:
Languages:  eng     Pagination:  133-41     Citation Subset:  IM    
Affiliation:
Departamento de Ciencias Fisiológicas, Escuela de Ciencias de la Salud, Núcleo Bolívar, Universidad Central de Venezuela, Caracas. frankrosa@cantv.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animal Structures / chemistry
Animals
Anti-Arrhythmia Agents / pharmacology,  therapeutic use
Antihypertensive Agents / pharmacology,  therapeutic use
Blood Pressure / drug effects
Calcium Channels / drug effects
Cardiotonic Agents / isolation & purification,  pharmacology*
Dihydroergotamine / pharmacology,  therapeutic use
Drug Evaluation, Preclinical
Enalapril / pharmacology,  therapeutic use
Ganglia, Invertebrate / drug effects
Heart Rate / drug effects
Hemodynamics / drug effects*
Hypertension / chemically induced,  prevention & control
Male
Motor Neurons / drug effects
Neuropeptides / isolation & purification,  pharmacology*
Penaeidae / chemistry*
Premedication
Propranolol / pharmacology,  therapeutic use
Rats
Rats, Sprague-Dawley
Receptors, Adrenergic, beta / drug effects
Tachycardia / chemically induced,  prevention & control
Tissue Extracts / isolation & purification,  pharmacology*
Verapamil / pharmacology,  therapeutic use
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Antihypertensive Agents; 0/Calcium Channels; 0/Cardiotonic Agents; 0/Neuropeptides; 0/Receptors, Adrenergic, beta; 0/Tissue Extracts; 511-12-6/Dihydroergotamine; 52-53-9/Verapamil; 525-66-6/Propranolol; 75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence and characterization of hearing loss in workers exposed to industrial noise of the turbog...
Next Document:  Anthropometric characteristics and skeletal maturity of male Venezuelan swimmers